Ensign Peak Advisors, Inc - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ensign Peak Advisors, Inc ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$226,193
-31.6%
20,250
+31.1%
0.00%
-100.0%
Q2 2023$330,630
-47.1%
15,4500.0%0.00%0.0%
Q1 2023$624,798
-11.6%
15,450
+1.6%
0.00%
-50.0%
Q4 2022$707,104
-61.3%
15,200
-56.9%
0.00%
-60.0%
Q3 2022$1,829,000
+13.5%
35,270
+3.5%
0.01%
+25.0%
Q2 2022$1,611,000
-40.6%
34,084
-10.5%
0.00%
-33.3%
Q1 2022$2,712,000
-4.8%
38,0950.0%0.01%
+20.0%
Q4 2021$2,849,000
+140.0%
38,095
+82.3%
0.01%
+150.0%
Q3 2021$1,187,000
+29.0%
20,9000.0%0.00%0.0%
Q2 2021$920,000
-8.5%
20,900
+2.5%
0.00%0.0%
Q1 2021$1,006,000
+41.5%
20,400
+20.7%
0.00%0.0%
Q4 2020$711,000
-8.1%
16,9000.0%0.00%0.0%
Q3 2020$774,000
-8.8%
16,9000.0%0.00%0.0%
Q2 2020$849,000
-2.3%
16,9000.0%0.00%
-33.3%
Q1 2020$869,000
-5.6%
16,900
+13.4%
0.00%
+50.0%
Q4 2019$921,00014,9000.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders